RABBITT ANTISERUM TO HUMAN C3C
Complement C3, Antigen, Antiserum, Control
DAKO CORP.
The following data is part of a premarket notification filed by Dako Corp. with the FDA for Rabbitt Antiserum To Human C3c.
Pre-market Notification Details
Device ID | K831905 |
510k Number | K831905 |
Device Name: | RABBITT ANTISERUM TO HUMAN C3C |
Classification | Complement C3, Antigen, Antiserum, Control |
Applicant | DAKO CORP. 803 N. Front St. Suite 3 Mchenry, IL 60050 |
Product Code | CZW |
CFR Regulation Number | 866.5240 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1983-06-14 |
Decision Date | 1983-07-18 |
NIH GUDID Devices
Device Identifier | submissionNumber | Supplement |
05700572002482 |
K831905 |
000 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.